Kirk Ways

2.8k citations

20 papers · 2.2k · 1 hit paper · h-index 15

Impact in

Endocrinology, Diabetes and Metabolism top 0.5%
- Diabetes Treatment and Management
- Diabetes Management and Research
Ophthalmology top 1%
- Retinal Diseases and Treatments

Papers in

Molecular Biology 8
- Metabolism, Diabetes, and Cancer 4
- Ubiquitin and proteasome pathways 2
- Retinal Development and Disorders 2
- Retinoids in leukemia and cellular processes 2
Endocrinology, Diabetes and Metabolism 8
- Diabetes Treatment and Management 7

Co-authors: Mehul Desai (3 shared papers)Gary Meininger (3 shared papers)Keith Usiskin (3 shared papers)Ngozi Erondu (1 shared paper)Julio Rosenstock (2 shared papers)Paul Nyirjesy (2 shared papers)George Capuano (3 shared papers)Chikako Takagi (2 shared papers)
Journals: Diabetes Care (3 papers)Current Medical Research and Opinion (3 papers)Endocrinology (1 paper)Toxicologic Pathology (1 paper)Blood (1 paper)
Partner nations: United States Belgium Australia

In The Last Decade

Kirk Ways

20 papers receiving 2.1k citations

Kirk Ways's Hit Papers

align trajectories log scale

Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitor 1997 · 569 citations

Peers

Countries citing papers authored by Kirk Ways

Since Specialization

Citations

This map shows the geographic impact of Kirk Ways's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk Ways with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk Ways more than expected).

Fields of papers citing papers by Kirk Ways

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirk Ways. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk Ways. The network helps show where Kirk Ways may publish in the future.

Co-authors

The 25 scholars most cited alongside Kirk Ways, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kirk Ways Line = papers co-authored together Kirk Ways links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitor Diabetes ·Lloyd Paul Aiello, Sven–Erik Bursell, Allen C. Clermont, Elia J. Duh, Hidehiro Ishii, Chikako Takagi, Fumi Mori, Thomas A. Ciulla, Kirk Ways, Michael R. Jirousek, Lois E. H. Smith, George L. King Hit paper breakdown →	1997	569
2	Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program Diabetes Care ·Ngozi Erondu, Mehul Desai, Kirk Ways, Gary Meininger	2015	250
3	Effect of Canagliflozin on Renal Threshold for Glucose, Glycemia, and Body Weight in Normal and Diabetic Animal Models PLoS ONE ·Yin Liang, Kenji Arakawa, Kiichiro Ueta, Yasuaki Matsushita, Chiaki Kuriyama, Tonya Martin, Fuyong Du, Yi Liu, June Xu, (unknown), Jamie Conway, David Polidori, Kirk Ways, Keith T. Demarest	2012	203
4	Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium–Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes Diabetes Care ·Bruce Neal, Vlado Perkovic, Dick de Zeeuw, Kenneth W. Mahaffey, Greg Fulcher, Kirk Ways, Mehul Desai, Wayne Shaw, George Capuano, Maria Alba, Joel Jiang, Frank Vercruysse, Gary Meininger, David R. Matthews, (unknown)	2014	193
5	Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin Diabetes Obesity and Metabolism ·Damayanthi Devineni, Linda Morrow, Marcus Hompesch, Donna Skee, An Vandebosch, Joseph Murphy, Kirk Ways, Sherwyn Schwartz	2012	193
6	Genital mycotic infections with canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus: a pooled analysis of clinical studies Current Medical Research and Opinion ·Paul Nyirjesy, Jack D. Sobel, Albert Fung, Cristiana Mayer, George Capuano, Kirk Ways, Keith Usiskin	2014	129
7	Evaluation of vulvovaginal symptoms and Candida colonization in women with type 2 diabetes mellitus treated with canagliflozin, a sodium glucose co-transporter 2 inhibitor Current Medical Research and Opinion ·Paul Nyirjesy, Yue Zhao, Kirk Ways, Keith Usiskin	2012	124
8	Insulin Glulisine Provides Improved Glycemic Control in Patients With Type 2 Diabetes Diabetes Care ·George Dailey, Julio Rosenstock, Robert G. Moses, Kirk Ways	2004	122
9	Optimized Basal-Bolus Insulin Regimens in Type 1 Diabetes: Insulin Glulisine Versus Regular Human Insulin in Combination with Basal Insulin Glargine Endocrine Practice ·Satish K. Garg, Julio Rosenstock, Kirk Ways	2005	87
10	Canagliflozin: a sodium glucose co‐transporter 2 inhibitor for the treatment of type 2 diabetes mellitus Annals of the New York Academy of Sciences ·Norm Rosenthal, Gary Meininger, Kirk Ways, David Polidori, Mehul Desai, Rong Qiu, Maria Alba, Frank Vercruysse, Dainius Balis, Wayne Shaw, Robert Edwards, Scott Bull, Nicholas A. Di Prospero, Sue Sha, Paul Rothenberg, William Canovatchel, Keith T. Demarest	2015	79
11	Effect of canagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, on bacteriuria and urinary tract infection in subjects with type 2 diabetes enrolled in a 12-week, phase 2 study Current Medical Research and Opinion ·Lindsay E. Nicolle, George Capuano, Kirk Ways, Keith Usiskin	2012	69
12	Effects of insulin and phorbol esters on subcellular distribution of protein kinase C isoforms in rat adipocytes Biochemical Journal ·Robert V. Farese, Mary L. Standaert, Alan François, Kirk Ways, Thomas Paul Arnold, Héctor H. Hernández, Denise R. Cooper	1992	65
13	Effects of insulin on diacylglycerol/protein kinase-C signalling and glucose transport in rat skeletal muscles in vivo and in vitro. Endocrinology ·Bao Yang Yu, Mary L. Standaert, T. Arnold, Héctor H. Hernández, James Watson, Kirk Ways, Denise R. Cooper, Robert V. Farese	1992	34
14	Effect of phorbol esters on cytosolic protein kinase C content and activity in the human monoblastoid U937 cell. Journal of Biological Chemistry ·Kirk Ways, RS Riddle, M Ways, Paul Cook	1991	31
15	Carbohydrate malabsorption mechanism for tumor formation in rats treated with the SGLT2 inhibitor canagliflozin Chemico-Biological Interactions ·Rao N. V. S. Mamidi, Jim Proctor, Sandra De Jonghe, Bianca Feyen, Esther Moesen, Petra Vinken, Ying Jing, Stewart Bryant, Sandra S. Snook, Calvert Louden, Godelieve Lammens, Kirk Ways, Michael F. Kelley, Mark D. Johnson	2014	19
16	Successful Integration of Nonclinical and Clinical Findings in Interpreting the Clinical Relevance of Rodent Neoplasia with a New Chemical Entity Toxicologic Pathology ·Kirk Ways, Mark D. Johnson, Rao N. V. S. Mamidi, James Proctor, Sandra De Jonghe, Calvert Louden	2014	10
17	2-Chloroadenosine prevents phorbol ester-induced depletion of protein kinase C in porcine coronary artery American Journal of Physiology-Heart and Circulatory Physiology ·R B Marala, Kirk Ways, S. Jamal Mustafa	1993	10
18	The metabolite 1 alpha,25-dihydroxyvitamin D3 enhances lymphokine- mediated activation of the oxidative metabolism of the U937 cell line and phosphorylation of a 48-kD respiratory burst-associated protein Blood ·RG Snipes, Kirk Ways, C DʼAmico, G Sivam, TK Gray, MS Cohen	1987	8
19	Vascular Endothelial Growth Factor-Induced Retinal Permeability is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform-Selective Inhibitor. Retina ·L P Aiello, S.E. Bursell, Allen C. Clermont, Elia J. Duh, Hiroko Ishii, Chikako Takagi, Fumihiko Mori, Thomas A. Ciulla, Kirk Ways, M.R. Jirousek, L E. H Smith, G L King	1998	6
20	Phorbol ester stimulated Cip1 expression in p53-negative leukemic cells Oncology Reports ·James DeVente, W O Bryant, Karla J. Posekany, T Garris, J Chen, J Carey, Paul W. Cook, Kirk Ways	1996	2

About Kirk Ways

Kirk Ways is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Surgery, Ophthalmology and Physiology, having authored 20 papers that have together received 2.2k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (7 papers), Metabolism, Diabetes, and Cancer (4 papers), Pancreatic function and diabetes (3 papers), Retinal Diseases and Treatments (2 papers), Ubiquitin and proteasome pathways (2 papers), Retinal Development and Disorders (2 papers), Retinoids in leukemia and cellular processes (2 papers) and Glaucoma and retinal disorders (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.3k citations), Ophthalmology (355 citations), Clinical Biochemistry (95 citations), Surgery (527 citations) and Nephrology (68 citations). Kirk Ways has collaborated with scholars based in United States, Belgium and Australia. Frequent co-authors include Mehul Desai, Gary Meininger, Keith Usiskin, Ngozi Erondu, Julio Rosenstock, Paul Nyirjesy, George Capuano, Chikako Takagi, Thomas A. Ciulla and Elia J. Duh. Their work appears in journals such as Diabetes Care, Current Medical Research and Opinion, Endocrinology, Toxicologic Pathology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Kirk Ways

Impact in

Papers in i

In The Last Decade

Kirk Ways

Kirk Ways's Hit Papers

Peers

Countries citing papers authored by Kirk Ways

Fields of papers citing papers by Kirk Ways

All Works

About Kirk Ways

Explore authors with similar magnitude of impact

Papers in